To compare the efficacy and safety of adding once - daily basal Glargine insulin versus switching to twice - daily premixed insulin in Type-II diabetic patients not well controlled by combined oral antidiabetic agents. In a 6 months parallel group clinical trail on 221 patients with Type-II diabetes and poorly controlled on oral antidiabetic agents (fasting blood glucose > 140 mg/ dl and glycosylated hemoglobin >8%) on oral antidiabetic treatment (metformin plus sulfonylurea) were randomized either to add Glargine insulin or to shift them to mixed insulin (30% regular insulin and 70% NPH) twice per day without oral antidiabetic treatment. Insulin dosage was titrated to target fasting blood glucose